Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

James Galloway

Showing results (21-30 of 207) with videos related to

Pageof 21
Sort By:
Clinical Rheumatology|April 27, 2020
Rheumatology care of migrants from sub-Saharan Africa: a literature review and qualitative pilot study of patients' perspectivesZoe Rutter-Locher, James Galloway, Heidi Lempp
The Lancet. Respiratory Medicine|November 9, 2025
Towards a new treatment era in sarcoidosisKatie Bechman, James Galloway, Surinder S Birring
Neuroscience|November 10, 2019
Evidence for a Contribution of the Nlgn3/Cyfip1/Fmr1 Pathway in the Pathophysiology of Autism Spectrum DisordersMonika Sledziowska, James Galloway, Stéphane J Baudouin
BMC Musculoskeletal Disorders|April 21, 2016
Is there a role of synovial biopsy in drug development?Maria Filkova, Andrew Cope, Tim Mant, et al.
Future Healthcare Journal|February 3, 2026
Rheumatology 2050: How our specialty is changingMariam Omar, Katie Bechman, Mark Russell, et al.
Annual International Conference of the IEEE Engineering in Medicine and Biology Society. IEEE Engineering in Medicine and Biology Society. Annual International Conference|November 17, 2018
Performance of Registration Tools on High-Resolution 3D Brain ImagesAbdullah Nazib, James Galloway, Clinton Fookes, et al.
Rheumatology (Oxford, England)|February 15, 2018
Comment on: Managing varicella zoster virus contact and infection in patients on anti-rheumatic therapyMatthew Cates, Matthew Donati, Sophie Gillet, et al.
Rheumatology Advances in Practice|May 11, 2026
Shingles vaccination before targeted therapy: why clear guidance isn't enoughHannah Kim, Nilay Joshi, Sara Naqvi, et al.
Expert Opinion on Pharmacotherapy|March 22, 2023
Conventional, biological disease-modifying anti-rheumatic drugs and Janus kinase inhibitors and varicella zoster virusFabiola Atzeni, Francesco Gozza, Agostino Riva, et al.
Rheumatology (Oxford, England)|May 5, 2021
The safety of JAK-1 inhibitorsBenjamin Clarke, Mark Yates, Maryam Adas, et al.
Pageof 21

Showing results (21-30 of 207) with videos related to

Sort By:
Pageof 21
Clinical Rheumatology|April 27, 2020
Rheumatology care of migrants from sub-Saharan Africa: a literature review and qualitative pilot study of patients' perspectivesZoe Rutter-Locher, James Galloway, Heidi Lempp
The Lancet. Respiratory Medicine|November 9, 2025
Towards a new treatment era in sarcoidosisKatie Bechman, James Galloway, Surinder S Birring
Neuroscience|November 10, 2019
Evidence for a Contribution of the Nlgn3/Cyfip1/Fmr1 Pathway in the Pathophysiology of Autism Spectrum DisordersMonika Sledziowska, James Galloway, Stéphane J Baudouin
BMC Musculoskeletal Disorders|April 21, 2016
Is there a role of synovial biopsy in drug development?Maria Filkova, Andrew Cope, Tim Mant, et al.
Future Healthcare Journal|February 3, 2026
Rheumatology 2050: How our specialty is changingMariam Omar, Katie Bechman, Mark Russell, et al.
Annual International Conference of the IEEE Engineering in Medicine and Biology Society. IEEE Engineering in Medicine and Biology Society. Annual International Conference|November 17, 2018
Performance of Registration Tools on High-Resolution 3D Brain ImagesAbdullah Nazib, James Galloway, Clinton Fookes, et al.
Rheumatology (Oxford, England)|February 15, 2018
Comment on: Managing varicella zoster virus contact and infection in patients on anti-rheumatic therapyMatthew Cates, Matthew Donati, Sophie Gillet, et al.
Rheumatology Advances in Practice|May 11, 2026
Shingles vaccination before targeted therapy: why clear guidance isn't enoughHannah Kim, Nilay Joshi, Sara Naqvi, et al.
Expert Opinion on Pharmacotherapy|March 22, 2023
Conventional, biological disease-modifying anti-rheumatic drugs and Janus kinase inhibitors and varicella zoster virusFabiola Atzeni, Francesco Gozza, Agostino Riva, et al.
Rheumatology (Oxford, England)|May 5, 2021
The safety of JAK-1 inhibitorsBenjamin Clarke, Mark Yates, Maryam Adas, et al.
Pageof 21